Rubric Capital Management (New York)’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-24,042	Closed	-$815K	–	93
2022 Q4	$815K	Hold	24,042	–	–	0.04%	91
2022 Q3	$1.18M	Hold	24,042	–	–	0.06%	83
2022 Q2	$945K	Buy	+24,042	New	+$945K	0.05%	85